Synta Pharmaceuticals (SNTA) announces a secondary offering for an undisclosed amount of shares. Jefferies is acting as sole book-running manager. Shares -11.5% AH.
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs